ウェアラブル注射器の市場規模、シェア、成長分析、タイプ別、技術別、適応症別、エンドユーザー別、地域別- 業界予測、2024～2031年

ウェアラブル注射器の世界市場規模は、2022年に66億6,000万米ドルと評価され、2023年の76億5,000万米ドルから2031年には238億9,000万米ドルに拡大し、予測期間（2024～2031年）のCAGRは15.29%で成長する見通しです。

ウェアラブル注射器は、患者とヘルスケア従事者双方の安全性を高め、注射針の挿入や抜去といった従来の注射方法に伴うリスクを大幅に軽減することで、患者ケアに革命をもたらしています。先進国、開発途上国を問わず医療費が高騰する中、この革新的な注射器は、高品質で安価な医療を提供するための解決策を提示しています。患者は自宅で便利に皮下注射を行うことができ、病院への通院や関連コストを削減することができます。ユーザーフレンドリーなデザインの注射器は、ユーザーがボタンで装置を作動させることができ、シームレスな針の挿入を保証します。薬剤投与後、注射針は自動的に引き込まれるため、針刺しによるケガの可能性はありません。この先進技術は、安全性を高めるだけでなく、注射プロセスを合理化し、現代のヘルスケアに不可欠な要素となっています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• ケーススタディ
• 顧客と購買基準の分析

ウェアラブル注射器の市場規模：タイプ別& CAGR（2024-2031）

• 市場概要
• オンボディ・ウェアラブル注射器
• オフボディ・ウェアラブル注射器
• デバイス専用ウェアラブル注射器

ウェアラブル注射器の市場規模：技術別& CAGR（2024-2031）

• 市場概要
• スプリングベース
• モーター駆動
• 拡張バッテリー
• ロータリーポンプ
• その他

ウェアラブル注射器の市場規模：適応症別& CAGR（2024-2031）

• 市場概要
• 糖尿病
• 免疫腫瘍学
• 心臓血管
• 慢性疼痛

ウェアラブル注射器の市場規模：エンドユーザー別& CAGR（2024-2031）

• 市場概要
• 病院・クリニック
• ホームケア
• その他

ウェアラブル注射器の市場規模：地域別& CAGR（2024-2031）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Becton Dickinson（BD）
• Insulet Corporation
• Ypsomed Holding AG
• Tandem Diabetes Care
• Enable Injections
• West Pharmaceutical Services
• Stevanato Group
• Eitan Medical
• Sensile Medical
• Buhler Motor
• United Therapeutics
• Dexcom
• CeQur
• Phillips-Medisize
• Medtronic
• Amgen
• Oval Medical Technologies
• Gerresheimer AG
• Terumo Corporation
• BioCorp

結論と推奨事項

Global Wearable Injectors Market size was valued at USD 6.66 billion in 2022 and is poised to grow from USD 7.65 billion in 2023 to USD 23.89 billion by 2031, growing at a CAGR of 15.29% in the forecast period (2024-2031).

Wearable injectors are revolutionizing patient care by enhancing safety for both patients and healthcare workers, significantly mitigating risks associated with traditional injection methods, such as needle insertion and removal. As healthcare costs rise in both developed and developing nations, these innovative injectors present a solution for delivering high-quality, affordable care. Patients can administer subcutaneous injections conveniently at home, reducing hospital visits and associated costs. With a user-friendly design, the injector allows users to activate the device with a button, ensuring seamless needle insertion. After medication delivery, the device retracts the needle automatically, eliminating the possibility of needle stick injuries. This advanced technology not only enhances safety but also streamlines the injection process, making it an essential component of modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Wearable Injectors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Wearable Injectors Market Segmental Analysis

Global Wearable Injectors Market is segmented by Type, Technology, Indications, End User and region. Based on Type, the market is segmented into On-body Wearable Injectors, Off-body Wearable Injectors, Device-Only Wearable Injectors. Based on Technology, the market is segmented into Spring-Based, Motor Drive, Expanding Battery, Rotary Pump, Other. Based on Indications, the market is segmented into Diabetes, Immuno- Oncology, Cardiovascular, Chronic Pain. Based on End User, the market is segmented into Hospital & Clinic, Homecare, Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Wearable Injectors Market

The growing prevalence of chronic diseases significantly fuels the expansion of the wearable injectors market. With a rise in the number of patients suffering from conditions such as diabetes, cardiovascular diseases, and cancer, the demand for these devices is surging. Wearable injectors offer a more convenient and less painful method for medication administration, which enhances patient adherence to treatment regimens. As the global burden of chronic illnesses escalates, particularly among the aging population, the adoption of wearable injectors is projected to rise. This trend reflects a broader shift toward innovative healthcare solutions that prioritize patient comfort and compliance.

Restraints in the Global Wearable Injectors Market

A significant constraint facing the global wearable injectors market is the elevated pricing associated with these devices. The integration of advanced technology and intricate manufacturing processes contributes to their high cost, rendering them less accessible to many users. This economic barrier presents a considerable challenge, particularly in developing and low-income regions, where affordability becomes a critical issue. As a result, the high prices of wearable injectors can hinder widespread adoption and limit market growth, creating disparities in access to these innovative healthcare solutions in different parts of the world.

Market Trends of the Global Wearable Injectors Market

The Global Wearable Injectors market is witnessing a significant trend towards personalized medicine, driven by the increasing development of biopharmaceutical products tailored to individual patient needs. As healthcare providers and manufacturers focus on delivering customized treatment regimens, wearable injectors are evolving to accommodate personalized medication delivery systems. This shift enhances patient outcomes by ensuring greater adherence and accuracy in drug administration. Furthermore, the rising demand for patient-centric solutions is revitalizing the market, fostering innovation in wearable injector technology that aligns with the broader trend of precision medicine, ultimately shaping the future of therapeutic delivery in healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis

Global Wearable Injectors Market Size by Type & CAGR (2024-2031)

• Market Overview
• On-body Wearable Injectors
• Off-body Wearable Injectors
• Device-Only Wearable Injectors

Global Wearable Injectors Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Spring-Based
• Motor Drive
• Expanding Battery
• Rotary Pump
• Other

Global Wearable Injectors Market Size by Indications & CAGR (2024-2031)

• Market Overview
• Diabetes
• Immuno- Oncology
• Cardiovascular
• Chronic Pain

Global Wearable Injectors Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospital & Clinic
• Homecare
• Other

Global Wearable Injectors Market Size & CAGR (2024-2031)

• North America, (Type, Technology, Indications, End User)
  • US
  • Canada
• Europe, (Type, Technology, Indications, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Type, Technology, Indications, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Type, Technology, Indications, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Type, Technology, Indications, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Becton Dickinson (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enable Injections
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eitan Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensile Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Buhler Motor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CeQur
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phillips-Medisize
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oval Medical Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCorp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation